BlackRock Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$162M Sell
2,209,331
-188,891
-8% -$14.1M 0.19% 108
2016
Q3
$192M Buy
2,398,222
+21,414
+0.9% +$1.71M 0.24% 92
2016
Q2
$187M Buy
2,376,808
+10,658
+0.5% +$802K 0.24% 91
2016
Q1
$170M Sell
2,366,150
-70,734
-3% -$5.35M 0.22% 93
2015
Q4
$205M Buy
2,436,884
+84,443
+4% +$7.01M 0.26% 88
2015
Q3
$197M Buy
2,352,441
+116,043
+5% +$9.8M 0.27% 84
2015
Q2
$187M Buy
2,236,398
+412,844
+23% +$31.5M 0.23% 95
2015
Q1
$132M Buy
1,823,554
+49,512
+3% +$3.52M 0.17% 127
2014
Q4
$122M Buy
1,774,042
+65,125
+4% +$4.4M 0.16% 136
2014
Q3
$111M Sell
1,708,917
-141,588
-8% -$8.96M 0.15% 135
2014
Q2
$115M Sell
1,850,505
-1,292,690
-41% -$77.1M 0.15% 138
2014
Q1
$185M Buy
3,143,195
+7,154
+0.2% +$399K 0.27% 82
2013
Q4
$160M Buy
3,136,041
+215,239
+7% +$10.8M 0.24% 97
2013
Q3
$147M Buy
2,920,802
+357,253
+14% +$18.7M 0.24% 94
2013
Q2
$126M Buy
+2,563,549
New +$139M 0.22% 96

Other funds holding LLY

BlackRock Investment Management's LLY Position: Q4 2016 in Review

BlackRock Investment Management reduced its Eli Lilly (LLY) stake by 7.9% in Q4 2016, selling an estimated $14.1M and leaving 2,209,331 shares worth $162M. The position accounts for 0.19% of the portfolio, ranked #108.

BlackRock Investment Management first reported a position in LLY in Q2 2013 and has held it in 15 quarters since. The position peaked at $205M in Q4 2015. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

  • BlackRock Investment Management held 2,209,331 shares of Eli Lilly worth $162M as of Q4 2016.
  • BlackRock Investment Management sold 188,891 Eli Lilly shares in Q4 2016, an estimated $14.1M.
  • Eli Lilly made up 0.19% of BlackRock Investment Management's portfolio in Q4 2016, its #108 holding.
  • BlackRock Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Eli Lilly position peaked at $205M in Q4 2015.
  • 1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.